🇺🇸 FDA
Patent

US 11337989

Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound

granted A61KA61K31/19A61K31/675

Quick answer

US patent 11337989 (Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound) held by Evofem, Inc. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Evofem, Inc.
Grant date
Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/19, A61K31/675, A61K31/734, A61K47/12